Results 1 to 10 of about 1,297,912 (266)
Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis
Background Cardiac amyloidosis is a protein misfolding disorder involving deposition of amyloid fibril proteins in the heart. The associated fibrosis of the conduction tissue results in conduction abnormalities and arrhythmias.
Perryn Lin Fei Ng+8 more
doaj +2 more sources
Background: In cardiac amyloidosis, the prevalence of thromboembolic events and atrial fibrillation is higher in transthyretin amyloidosis compared to immunoglobulin light chain amyloidosis.
Mathijs O. Versteylen+3 more
doaj +2 more sources
Amyloidosis is a protein deposition disorder in which insoluble fibril structures accumulate in the bodily tissues damaging the organ function. Cardiac amyloidosis is a severe but under-reported medical condition characterized by the accumulation of ...
Gnana Deepthi Medarametla+9 more
doaj +2 more sources
Clinical Clues and Diagnostic Workup of Cardiac Amyloidosis
Cardiac amyloidosis is increasingly recognized as an underlying cause of left ventricular wall thickening, heart failure, and arrhythmia with variable clinical presentation.
Sajan S. Gill+4 more
doaj +2 more sources
Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies [PDF]
Background/Objectives: Cardiac amyloidosis (CA) is an underdiagnosed and potentially life-threatening infiltrative cardiomyopathy characterized by the extracellular deposition of misfolded amyloid fibrils in cardiac tissue. It is most commonly associated
Dana Emilia Movila+7 more
doaj +2 more sources
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions ...
P. García-Pavía+23 more
semanticscholar +1 more source
Background. Heart transplantation in cardiac amyloidosis (CA) patients is possible and generally considered for transplantation if other organs are not affected.
Soulef Guendouz, MD+27 more
doaj +1 more source
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
BACKGROUND Transthyretin amyloidosis, also called ATTR amyloidosis, is associated with accumulation of ATTR amyloid deposits in the heart and commonly manifests as progressive cardiomyopathy. Patisiran, an RNA interference therapeutic agent, inhibits the
M. S. Maurer+36 more
semanticscholar +1 more source
A case of cardiac amyloidosis incidentally detected by bone scintigraphy [PDF]
A 73-year-old man with lung cancer underwent bone scintigraphy for disease staging. Diffuse myocardial technetium hydroxymethylene diphosphonate (99mTc-HMDP) uptake was incidentally found.
Hiroki Tanaka+7 more
doaj +1 more source
Cardiac amyloidosis and aortic stenosis: a state-of-the-art review
Cardiac amyloidosis is caused by the extracellular deposition of amyloid fibrils in the heart, involving not only the myocardium but also any cardiovascular structure.
Vikash Jaiswal+14 more
semanticscholar +1 more source